SlideShare a Scribd company logo
Hodgkin's lymphoma
(Hodgkin's disease)
ODAI RJOUB (STUDENT) - HEBRON UNIVERSITY-
BIOLOGY DEPARTMENT-
Def:
is a chronic ( in rare case acute) disease ,the growth of the
tumor cells take place mainly in the lymphatic node.
Hodgkin's disease, is a type of lymphoma, which is a type of
cancer originating from white blood cells called
lymphocytes.
History:
It was named after Dr. Thomas Hodgkin, who
first described abnormalities in the lymph system in
1832.
Dorothy Reed and Carl Stenberg first
described the malignant cells of Hodgkin’s lymphoma
called Reed Stenberg cells.
1798-1866
Sign and symptoms:(Clinical features)
 Night Sweats
 Unexplained weight loss
 Lymph nodes: the most common symptom of Hodgkin's is the
painless enlargement of one or more lymph nodes. The nodes
may also feel rubbery and swollen when examined
 Splenomegaly: enlargement of the spleen occurs in about 30%
of people with Hodgkin's lymphoma
 Hepatomegaly: enlargement of the liver
1. Painless Lymphadenopathy –
involving superficial lymph nodes of cervical and (Dsupraclavicular
nodes)
• The lymph nodes are swollen and have a rubbery feeling
2. Systemic Symptoms
a) Fevers, Night Sweats and Weight Loss
b) Pruritus
c) Pel-Ebstein Fever
e) cough and dyspnoea.
3. Pain
a) Alcohol – induced pain
b) Abdominal Pain
c) Bone Pain
d) Neurogenic Pain
e) Back Pain
f) chest pain
Famous People With Hodgkin's Disease:
• Paul Allen- Investor and co-founder of Microsoft
Corporation.
• Charles Lindbergh- The first pilot to make a transatlantic
flight.
• Jackie Kennedy- Former First Lady
• Gene Wilder- Actor
Causes:
 The exact cause of Hodgkin's lymphoma is unknown
Hodgkin's lymphoma commonly begins in lymph nodes
located in the upper part of your body.
Some lymph nodes are in areas more readily noticed, such as
in your neck, above your collarbone, under your arms or in
your groin area.
 Enlarged lymph nodes in the chest cavity also are common.
Eventually, Hodgkin's lymphoma may spread outside your
lymph nodes to virtually any part of your body.
 A key step in Hodgkin's lymphoma involves the
development of abnormal B cells.
REAL* Classification
Classic:
1. Nodular Sclerosis
2.Lymhocyte rich
3. Mixed Cellularity
4. Lymphocyte depleted
Non-Classic:
Nodular lymphocyte predominant Hodgkins lymphoma
(NLPHL)
Classic:
1.Nodular Sclerosis:
Most common type diagnosed.
About 70% of adolescents
 Lacunar cells are seen
40% of younger patients
CD 15 and 30 positive
EBV negative
Only subtype without a male predominance
Seen in younger pts with stage I – II disease
2. Lymphocyte-Rich:
This was introduced by the World
Health Organization classification in
1999.
RS cells CD15+, CD30+; 40% EBV+
Uncommon
M > F
Tends to be seen in older adults
This is an uncommon form of classical HL
3. Mixed Cellularity:
Constitutes about 20%
 More common in young children
CD 15,30 EBV positive
Presents in advanced stages
Tendency to involve spleen , bone marrow
 More than 50% present as stage III or IV disease
Biphasic incidence, peaking in young adults and again in adults
older than 55
4. Lymphocyte depleted:
Constitutes <5%
RS cells CD15+, CD30+; most EBV+
Worst prognosis of all subtypes
Present as febrile illness with
pancytopenia, hepatomegaly,
and no peripheral lymphadenopathy
Older males , rare in children
Advanced stage , Stage IV
 HIV infection
Non-Classic:
Lymphocyte predominant Hodgkins lymphoma
<5% of Hodgkins lymphoma
Mainly involves cervical ,
axillary or mediastinal
“L&H” cells or Popcorn
cells are seen
Positive for CD20,45
Negative for CD15,30.EBV
Ann Arbor Staging Classification for
Hodgkin Disease:
Stage I:
Involvement of a single lymph node (1) or of a single
extra lymphatic site or organ(1f)
 Stage II:
Involvement of two or more lymph node regions
on the same side of the diaphragm(II)
or localised involvement of an extra lymphatic
Site or organ and one or more lymph node regions
on the same side of the diaphragm (IIf)
Stage III:
Involvement of lymph node regions on both sides of
the diaphragm (III) which may be accompanied by the
involvement of spleen (IIIS) or by localized involvement of
an extra lymphatic site or organ ( IIIf) or both ( IIIsf)
Stage IV:
Diffuse or disseminated involvement of one or more
extra lymphatic organs or tissues with or without associated
lymph node involvement. involvement of liver or bone
marrow
Epidemiology:
Most frequently (Bimodal)occur in age group 15 to 35 and >50
years
More common in males except Nodular Sclerosis which is more
common in females
Increase incidence in HIV infections.
Bimodal incidence
Early peak middle to late 20s Second peak after 50 yearr
Immunodeficiency
Sex (Male : Female)
4: 1 for 3-7 yr
3: 1 for 7-9 yr
1-3: 1 for > 10 yr
100 folds risk for unaffected monozygotic twin of affected
twin
Associated with specific HLA antigen
Infectious agents
Human herpes virus 6
CMV
Epstein – Barr virus
Risk Factors Hodgkins:
Family History
 Environmental – wood workers, farmers, meat workers
Diseases- Mononucleosis (EBV infection), AIDS, Bone marrow
transplant.
HIV
Complication:
 Renal amyloidosis followed by contracted kidney and uremia
 Intoxication
 Septic complication
 Cardiovascular disease
 Second malignancy, such as leukemia, non-Hodgkin's lymphoma
and tumors in the lungs, breasts or gastrointestinal system
 Vascular disease, including stroke
 Thyroid dysfunction
 Sterility
Diagnostic:
 CBC
 LIVER FUNCTION
 RENAL FUNCTION
 SERUM ALBUMIN
 Serum Copper & Ferritin
 ESR
 LACTEATE DEHYDROGENASE
 BONE MAROW BIOBSEY
Bone Marrow Biopsy:
PET SCAN:
TREATMENT:
Treatment depends on :
Stage of the disease
Age at diagnosis
Presence / absence of B symptoms
Presence of hilar lymphadenopathy
Presence of bulky nodal disease
Current Treatment Regimen:
Combined chemotherapy with or without low
dose involved field radiation therapy.
1.Chemotherapy:
MOPP
COPP
ABVD
 BEACOPP
Radiotherapy:
 Radiation therapy is the most effective single thrapeutic
agent for treating Hodgkin lymphoma.
The main objective of radiation in Hodgkin lymphoma is
to treat involved and contiguous field.
Radiotherapy can be given by
1. 2D planning
2. 3D planning
3. IFRT
Involved field radiotherapy is the most commonly used
technique at present. It targets a smaller area rather than a
classical extended field.
Conclusion:
Radiation therapy is the most effective single therapeutic
agent for treating Hodgkins lymphoma
The management of Hodgkins lymphoma has evolved from
extended field radiation to a combined modality of chemo
radiation or chemo alone.
Interest is in achieving the best therapeutic ratio by
minimizing late toxicity while maintaining effectiveness.
With improvement in diagnostic modality and PET
scanning and improved treatment policy the results in
future will be encouraging
IFRT
Involved field radiotherapy.
IFRT is the most commonly used technique at present
Targets a smaller area rather than a classical extended field.
IFRT(ASTRO 2002)DEFINITION
IFRT encompasses region and not an individual lymph node.
Initially involved Pre chemo sites and volume are treated
Exception to above rule is for transverse diameter of
mediastinum and paraaortic lymphnodes for which reduced post
chemo volume is treated.
Thank you

More Related Content

What's hot

Lymphoma
Lymphoma Lymphoma
Lymphoma
OM VERMA
 
Non hodgkin lymphoma
Non hodgkin lymphomaNon hodgkin lymphoma
Non hodgkin lymphoma
tashagarwal
 
Non hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhuNon hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhu
Indhu Reddy
 
Hodgkin lymphoma
Hodgkin lymphomaHodgkin lymphoma
Hodgkin lymphoma
Ranjita Pallavi
 
Acute leukemias
Acute leukemiasAcute leukemias
Acute leukemias
Vijay Shankar
 
Lymphoma
LymphomaLymphoma
Lymphoma
Mahesh Raj
 
Hodgkin lymphoma
Hodgkin lymphomaHodgkin lymphoma
Hodgkin lymphoma
tashagarwal
 
Thyroiditis by Dr Selim
Thyroiditis by Dr SelimThyroiditis by Dr Selim
Non hodgkin's lymphoma
Non hodgkin's lymphomaNon hodgkin's lymphoma
Non hodgkin's lymphoma
rahulverma1194
 
Lymphoma
LymphomaLymphoma
Paraneoplastic Syndromes
Paraneoplastic SyndromesParaneoplastic Syndromes
Paraneoplastic Syndromes
Dr. Roopam Jain
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphomaChandan N
 
Lymphoma
LymphomaLymphoma
Lecture 10. multiple endocrine neoplasia syndrome (men)
Lecture 10. multiple endocrine neoplasia syndrome (men)Lecture 10. multiple endocrine neoplasia syndrome (men)
Lecture 10. multiple endocrine neoplasia syndrome (men)
Ayub Abdi
 
Non-Hodgkin’s Lymphoma (NHL).ppt
Non-Hodgkin’s Lymphoma (NHL).pptNon-Hodgkin’s Lymphoma (NHL).ppt
Non-Hodgkin’s Lymphoma (NHL).ppt
Dr. Indranil Bhattacharya
 
Hodgkins & Non-Hodgkins Lymphomas
Hodgkins & Non-Hodgkins LymphomasHodgkins & Non-Hodgkins Lymphomas
Hodgkins & Non-Hodgkins Lymphomas
Dinoosh De Livera
 

What's hot (20)

Lymphoma
Lymphoma Lymphoma
Lymphoma
 
Non hodgkin lymphoma
Non hodgkin lymphomaNon hodgkin lymphoma
Non hodgkin lymphoma
 
Non hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhuNon hodgkins lymphoma nandhu
Non hodgkins lymphoma nandhu
 
Hodgkin lymphoma
Hodgkin lymphomaHodgkin lymphoma
Hodgkin lymphoma
 
Acute leukemias
Acute leukemiasAcute leukemias
Acute leukemias
 
Sarcoidosis
SarcoidosisSarcoidosis
Sarcoidosis
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Hodgkin lymphoma
Hodgkin lymphomaHodgkin lymphoma
Hodgkin lymphoma
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Thyroiditis by Dr Selim
Thyroiditis by Dr SelimThyroiditis by Dr Selim
Thyroiditis by Dr Selim
 
Non hodgkin's lymphoma
Non hodgkin's lymphomaNon hodgkin's lymphoma
Non hodgkin's lymphoma
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Nhl
NhlNhl
Nhl
 
Paraneoplastic Syndromes
Paraneoplastic SyndromesParaneoplastic Syndromes
Paraneoplastic Syndromes
 
Non hodgkins lymphoma
Non hodgkins lymphomaNon hodgkins lymphoma
Non hodgkins lymphoma
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Lecture 10. multiple endocrine neoplasia syndrome (men)
Lecture 10. multiple endocrine neoplasia syndrome (men)Lecture 10. multiple endocrine neoplasia syndrome (men)
Lecture 10. multiple endocrine neoplasia syndrome (men)
 
Hodgkin lymphoma
Hodgkin lymphomaHodgkin lymphoma
Hodgkin lymphoma
 
Non-Hodgkin’s Lymphoma (NHL).ppt
Non-Hodgkin’s Lymphoma (NHL).pptNon-Hodgkin’s Lymphoma (NHL).ppt
Non-Hodgkin’s Lymphoma (NHL).ppt
 
Hodgkins & Non-Hodgkins Lymphomas
Hodgkins & Non-Hodgkins LymphomasHodgkins & Non-Hodgkins Lymphomas
Hodgkins & Non-Hodgkins Lymphomas
 

Similar to hodgkins lymphoma

Hodgkin and non-hodgkins lymphoma.pptx
Hodgkin and non-hodgkins lymphoma.pptxHodgkin and non-hodgkins lymphoma.pptx
Hodgkin and non-hodgkins lymphoma.pptx
Dr.Jitendra Patel
 
Lymphoma
LymphomaLymphoma
Lymphoma
rahulverma1194
 
HODGKIN LYMPHOMA & NON HODGKIN LYMPHOMA
HODGKIN LYMPHOMA & NON HODGKIN LYMPHOMAHODGKIN LYMPHOMA & NON HODGKIN LYMPHOMA
HODGKIN LYMPHOMA & NON HODGKIN LYMPHOMA
HARSHITA
 
nhlhl-190521214936.pdf
nhlhl-190521214936.pdfnhlhl-190521214936.pdf
nhlhl-190521214936.pdf
Komal827633
 
lymphoma 16-3-2023 dr masoud.ppt
lymphoma 16-3-2023 dr masoud.pptlymphoma 16-3-2023 dr masoud.ppt
lymphoma 16-3-2023 dr masoud.ppt
masoud53
 
Lymphoma
Lymphoma Lymphoma
Hodgkin's lymphoma
Hodgkin's lymphomaHodgkin's lymphoma
Hodgkin's lymphoma
yograj banteria
 
Malignant Diseases Lymphatics & Soft Tissue #3
Malignant Diseases Lymphatics & Soft Tissue #3Malignant Diseases Lymphatics & Soft Tissue #3
Malignant Diseases Lymphatics & Soft Tissue #3guest3757e6
 
hodgkinslymphoma-180110160802.pptx
hodgkinslymphoma-180110160802.pptxhodgkinslymphoma-180110160802.pptx
hodgkinslymphoma-180110160802.pptx
AdwaitPaithankar1
 
Paithankar Adwait 7610 m2a Hodgkins Lymphoma hemat.pptx
Paithankar Adwait 7610 m2a Hodgkins Lymphoma hemat.pptxPaithankar Adwait 7610 m2a Hodgkins Lymphoma hemat.pptx
Paithankar Adwait 7610 m2a Hodgkins Lymphoma hemat.pptx
AdwaitPaithankar1
 
Adcetris 50 mg: Prescription Only Drug
Adcetris 50 mg: Prescription Only DrugAdcetris 50 mg: Prescription Only Drug
Adcetris 50 mg: Prescription Only Drug
jhonpharma1
 
ADCETRIS: Hodgkin's Lymphoma Treatment
ADCETRIS: Hodgkin's Lymphoma TreatmentADCETRIS: Hodgkin's Lymphoma Treatment
ADCETRIS: Hodgkin's Lymphoma Treatment
riyakimm
 
Lymphoma
LymphomaLymphoma
Lymphoma
LymphomaLymphoma
pulmonary maifestaion of hodgkin and non hodgkin lymphoma
pulmonary maifestaion of hodgkin and non hodgkin lymphomapulmonary maifestaion of hodgkin and non hodgkin lymphoma
pulmonary maifestaion of hodgkin and non hodgkin lymphoma
Nasir Ali Zaki
 
hl.ppt
hl.ppthl.ppt
Lymphoma
LymphomaLymphoma
Phamacotherapy for Hodgkin's lymphoma
Phamacotherapy for Hodgkin's lymphomaPhamacotherapy for Hodgkin's lymphoma
Phamacotherapy for Hodgkin's lymphoma
Koppala RVS Chaitanya
 

Similar to hodgkins lymphoma (20)

Hodgkin and non-hodgkins lymphoma.pptx
Hodgkin and non-hodgkins lymphoma.pptxHodgkin and non-hodgkins lymphoma.pptx
Hodgkin and non-hodgkins lymphoma.pptx
 
06 Lymphoma-1.ppt
06 Lymphoma-1.ppt06 Lymphoma-1.ppt
06 Lymphoma-1.ppt
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
HODGKIN LYMPHOMA & NON HODGKIN LYMPHOMA
HODGKIN LYMPHOMA & NON HODGKIN LYMPHOMAHODGKIN LYMPHOMA & NON HODGKIN LYMPHOMA
HODGKIN LYMPHOMA & NON HODGKIN LYMPHOMA
 
nhlhl-190521214936.pdf
nhlhl-190521214936.pdfnhlhl-190521214936.pdf
nhlhl-190521214936.pdf
 
lymphoma 16-3-2023 dr masoud.ppt
lymphoma 16-3-2023 dr masoud.pptlymphoma 16-3-2023 dr masoud.ppt
lymphoma 16-3-2023 dr masoud.ppt
 
lymphoma
lymphomalymphoma
lymphoma
 
Lymphoma
Lymphoma Lymphoma
Lymphoma
 
Hodgkin's lymphoma
Hodgkin's lymphomaHodgkin's lymphoma
Hodgkin's lymphoma
 
Malignant Diseases Lymphatics & Soft Tissue #3
Malignant Diseases Lymphatics & Soft Tissue #3Malignant Diseases Lymphatics & Soft Tissue #3
Malignant Diseases Lymphatics & Soft Tissue #3
 
hodgkinslymphoma-180110160802.pptx
hodgkinslymphoma-180110160802.pptxhodgkinslymphoma-180110160802.pptx
hodgkinslymphoma-180110160802.pptx
 
Paithankar Adwait 7610 m2a Hodgkins Lymphoma hemat.pptx
Paithankar Adwait 7610 m2a Hodgkins Lymphoma hemat.pptxPaithankar Adwait 7610 m2a Hodgkins Lymphoma hemat.pptx
Paithankar Adwait 7610 m2a Hodgkins Lymphoma hemat.pptx
 
Adcetris 50 mg: Prescription Only Drug
Adcetris 50 mg: Prescription Only DrugAdcetris 50 mg: Prescription Only Drug
Adcetris 50 mg: Prescription Only Drug
 
ADCETRIS: Hodgkin's Lymphoma Treatment
ADCETRIS: Hodgkin's Lymphoma TreatmentADCETRIS: Hodgkin's Lymphoma Treatment
ADCETRIS: Hodgkin's Lymphoma Treatment
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
pulmonary maifestaion of hodgkin and non hodgkin lymphoma
pulmonary maifestaion of hodgkin and non hodgkin lymphomapulmonary maifestaion of hodgkin and non hodgkin lymphoma
pulmonary maifestaion of hodgkin and non hodgkin lymphoma
 
hl.ppt
hl.ppthl.ppt
hl.ppt
 
Lymphoma
LymphomaLymphoma
Lymphoma
 
Phamacotherapy for Hodgkin's lymphoma
Phamacotherapy for Hodgkin's lymphomaPhamacotherapy for Hodgkin's lymphoma
Phamacotherapy for Hodgkin's lymphoma
 

Recently uploaded

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 

Recently uploaded (20)

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 

hodgkins lymphoma

  • 1. Hodgkin's lymphoma (Hodgkin's disease) ODAI RJOUB (STUDENT) - HEBRON UNIVERSITY- BIOLOGY DEPARTMENT-
  • 2. Def: is a chronic ( in rare case acute) disease ,the growth of the tumor cells take place mainly in the lymphatic node. Hodgkin's disease, is a type of lymphoma, which is a type of cancer originating from white blood cells called lymphocytes.
  • 3. History: It was named after Dr. Thomas Hodgkin, who first described abnormalities in the lymph system in 1832. Dorothy Reed and Carl Stenberg first described the malignant cells of Hodgkin’s lymphoma called Reed Stenberg cells. 1798-1866
  • 4. Sign and symptoms:(Clinical features)  Night Sweats  Unexplained weight loss  Lymph nodes: the most common symptom of Hodgkin's is the painless enlargement of one or more lymph nodes. The nodes may also feel rubbery and swollen when examined  Splenomegaly: enlargement of the spleen occurs in about 30% of people with Hodgkin's lymphoma  Hepatomegaly: enlargement of the liver
  • 5. 1. Painless Lymphadenopathy – involving superficial lymph nodes of cervical and (Dsupraclavicular nodes) • The lymph nodes are swollen and have a rubbery feeling 2. Systemic Symptoms a) Fevers, Night Sweats and Weight Loss b) Pruritus c) Pel-Ebstein Fever e) cough and dyspnoea. 3. Pain a) Alcohol – induced pain b) Abdominal Pain c) Bone Pain d) Neurogenic Pain e) Back Pain f) chest pain
  • 6. Famous People With Hodgkin's Disease: • Paul Allen- Investor and co-founder of Microsoft Corporation. • Charles Lindbergh- The first pilot to make a transatlantic flight. • Jackie Kennedy- Former First Lady • Gene Wilder- Actor
  • 7. Causes:  The exact cause of Hodgkin's lymphoma is unknown Hodgkin's lymphoma commonly begins in lymph nodes located in the upper part of your body. Some lymph nodes are in areas more readily noticed, such as in your neck, above your collarbone, under your arms or in your groin area.  Enlarged lymph nodes in the chest cavity also are common. Eventually, Hodgkin's lymphoma may spread outside your lymph nodes to virtually any part of your body.  A key step in Hodgkin's lymphoma involves the development of abnormal B cells.
  • 8. REAL* Classification Classic: 1. Nodular Sclerosis 2.Lymhocyte rich 3. Mixed Cellularity 4. Lymphocyte depleted Non-Classic: Nodular lymphocyte predominant Hodgkins lymphoma (NLPHL)
  • 9. Classic: 1.Nodular Sclerosis: Most common type diagnosed. About 70% of adolescents  Lacunar cells are seen 40% of younger patients CD 15 and 30 positive EBV negative Only subtype without a male predominance Seen in younger pts with stage I – II disease
  • 10. 2. Lymphocyte-Rich: This was introduced by the World Health Organization classification in 1999. RS cells CD15+, CD30+; 40% EBV+ Uncommon M > F Tends to be seen in older adults This is an uncommon form of classical HL
  • 11. 3. Mixed Cellularity: Constitutes about 20%  More common in young children CD 15,30 EBV positive Presents in advanced stages Tendency to involve spleen , bone marrow  More than 50% present as stage III or IV disease Biphasic incidence, peaking in young adults and again in adults older than 55
  • 12. 4. Lymphocyte depleted: Constitutes <5% RS cells CD15+, CD30+; most EBV+ Worst prognosis of all subtypes Present as febrile illness with pancytopenia, hepatomegaly, and no peripheral lymphadenopathy Older males , rare in children Advanced stage , Stage IV  HIV infection
  • 13. Non-Classic: Lymphocyte predominant Hodgkins lymphoma <5% of Hodgkins lymphoma Mainly involves cervical , axillary or mediastinal “L&H” cells or Popcorn cells are seen Positive for CD20,45 Negative for CD15,30.EBV
  • 14. Ann Arbor Staging Classification for Hodgkin Disease: Stage I: Involvement of a single lymph node (1) or of a single extra lymphatic site or organ(1f)  Stage II: Involvement of two or more lymph node regions on the same side of the diaphragm(II) or localised involvement of an extra lymphatic Site or organ and one or more lymph node regions on the same side of the diaphragm (IIf)
  • 15. Stage III: Involvement of lymph node regions on both sides of the diaphragm (III) which may be accompanied by the involvement of spleen (IIIS) or by localized involvement of an extra lymphatic site or organ ( IIIf) or both ( IIIsf) Stage IV: Diffuse or disseminated involvement of one or more extra lymphatic organs or tissues with or without associated lymph node involvement. involvement of liver or bone marrow
  • 16. Epidemiology: Most frequently (Bimodal)occur in age group 15 to 35 and >50 years More common in males except Nodular Sclerosis which is more common in females Increase incidence in HIV infections. Bimodal incidence Early peak middle to late 20s Second peak after 50 yearr Immunodeficiency
  • 17. Sex (Male : Female) 4: 1 for 3-7 yr 3: 1 for 7-9 yr 1-3: 1 for > 10 yr 100 folds risk for unaffected monozygotic twin of affected twin Associated with specific HLA antigen Infectious agents Human herpes virus 6 CMV Epstein – Barr virus
  • 18. Risk Factors Hodgkins: Family History  Environmental – wood workers, farmers, meat workers Diseases- Mononucleosis (EBV infection), AIDS, Bone marrow transplant. HIV
  • 19. Complication:  Renal amyloidosis followed by contracted kidney and uremia  Intoxication  Septic complication  Cardiovascular disease  Second malignancy, such as leukemia, non-Hodgkin's lymphoma and tumors in the lungs, breasts or gastrointestinal system  Vascular disease, including stroke  Thyroid dysfunction  Sterility
  • 21.  CBC  LIVER FUNCTION  RENAL FUNCTION  SERUM ALBUMIN  Serum Copper & Ferritin  ESR  LACTEATE DEHYDROGENASE  BONE MAROW BIOBSEY
  • 24. TREATMENT: Treatment depends on : Stage of the disease Age at diagnosis Presence / absence of B symptoms Presence of hilar lymphadenopathy Presence of bulky nodal disease Current Treatment Regimen: Combined chemotherapy with or without low dose involved field radiation therapy.
  • 26. Radiotherapy:  Radiation therapy is the most effective single thrapeutic agent for treating Hodgkin lymphoma. The main objective of radiation in Hodgkin lymphoma is to treat involved and contiguous field. Radiotherapy can be given by 1. 2D planning 2. 3D planning 3. IFRT Involved field radiotherapy is the most commonly used technique at present. It targets a smaller area rather than a classical extended field.
  • 27. Conclusion: Radiation therapy is the most effective single therapeutic agent for treating Hodgkins lymphoma The management of Hodgkins lymphoma has evolved from extended field radiation to a combined modality of chemo radiation or chemo alone. Interest is in achieving the best therapeutic ratio by minimizing late toxicity while maintaining effectiveness. With improvement in diagnostic modality and PET scanning and improved treatment policy the results in future will be encouraging
  • 28. IFRT Involved field radiotherapy. IFRT is the most commonly used technique at present Targets a smaller area rather than a classical extended field. IFRT(ASTRO 2002)DEFINITION IFRT encompasses region and not an individual lymph node. Initially involved Pre chemo sites and volume are treated Exception to above rule is for transverse diameter of mediastinum and paraaortic lymphnodes for which reduced post chemo volume is treated.